Decreased Expression of Enterocyte Nutrient Assimilation Genes and Proteins in the Small Intestine of Cystic Fibrosis Mouse

被引:13
作者
De Lisle, Robert C. [1 ]
机构
[1] Univ Kansas, Sch Med, Anat & Cell Biol, Kansas City, KS 66160 USA
关键词
intestine; cystic fibrosis; enterocyte; BACTERIAL OVERGROWTH; MUSCLE DYSFUNCTION; KNOCKOUT MICE; CFTR; INFLAMMATION; SURVIVAL; BICARBONATE; OUTCOMES; TRANSIT;
D O I
10.1097/MPG.0000000000001030
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Cystic fibrosis (CF) has major effects on the intestinal tract with potential consequences on nutrition, but these are not fully understood. I investigated the possibility of altered enterocyte maturation in CF, as suggested by decreased enterocyte nutrient assimilation gene expression in published transcriptome analysis of the small intestine of CF mouse. Methods: In CF and wild-type (WT) mice, enterocyte gene/protein expression was analyzed by quantitative realtime polymerase chain reaction (qRT-PCR), enzyme histochemistry, immunohistochemistry, and Western blot. One group of mice was maintained on a control liquid diet; to manipulate the gut microbiota, a second group was treated with oral antibiotics; to improve hydration of the gut lumen, a third group was given a laxative drinking solution. Results: On the control diet in the CF intestine, there were decreased levels (67%-85% reduction of WT levels) of enterocyte genes/proteins. Antibiotics did not normalize the expression of enterocyte markers in the CF mouse. In contrast, the laxative treatment of CF mice significantly increased expression to near WT levels. Conclusions: These studies suggest that the environment of the CF intestinal lumen plays a role in reduced maturation of enterocytes. Because changing the gut lumen environment can affect enterocyte maturation, this is not a cell-autonomous effect of loss of CF transmembrane conductance regulator.
引用
收藏
页码:627 / 634
页数:8
相关论文
共 43 条
[1]   Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis [J].
Baker, SS ;
Borowitz, D ;
Duffy, L ;
Fitzpatrick, L ;
Gyamfi, J ;
Baker, RD .
JOURNAL OF PEDIATRICS, 2005, 146 (02) :189-193
[2]   IMPROVED METHOD FOR OBTAINING 3-MU-M CRYOSECTIONS FOR IMMUNOCYTOCHEMISTRY [J].
BARTHEL, LK ;
RAYMOND, PA .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (09) :1383-1388
[3]   Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome [J].
Bazett, Mark ;
Honeyman, Lisa ;
Stefanov, Anguel N. ;
Pope, Christopher E. ;
Hoffman, Lucas R. ;
Haston, Christina K. .
MAMMALIAN GENOME, 2015, 26 (5-6) :222-234
[4]   Gastrointestinal outcomes and confounders in cystic fibrosis [J].
Borowitz, D ;
Durie, PR ;
Clarke, LL ;
Werlin, SL ;
Taylor, CJ ;
Semler, J ;
De Lisle, RC ;
Lewindon, P ;
Lichtman, SM ;
Sinaasappel, M ;
Baker, RD ;
Baker, SS ;
Verkade, HJ ;
Lowe, ME ;
Stallings, VA ;
Janghorbani, M ;
Butler, R ;
Heubi, J .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 41 (03) :273-285
[5]  
Bradley GM, 2012, AM J CLIN NUTR, V92, P173
[6]   Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice [J].
Canale-Zambrano, Juan C. ;
Auger, Meagan L. ;
Haston, Christina K. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 299 (02) :G381-G390
[7]   A new role for bicarbonate in mucus formation [J].
Chen, Eric Y. T. ;
Yang, Ning ;
Quinton, Paul M. ;
Chin, Wei-Chun .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2010, 299 (04) :L542-L549
[8]   Inflammation and anti-inflammatory therapies for cystic fibrosis [J].
Chmiel, James F. ;
Konstan, Michael W. .
CLINICS IN CHEST MEDICINE, 2007, 28 (02) :331-+
[9]  
Clarke LL, 1996, LAB ANIM SCI, V46, P612
[10]  
Davidson D J, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002551